Nello Mainolfi Kymera Therapeutics, Inc. (KYMR) insider trading activity

Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 660,482 shares of KYMR, which is worth approximately $30.6 Million. The most recent transaction as insider was on May 12, 2021, when has been sold 8,245 shares (Common Stock) at a price of $50.05 per share, resulting in proceeds of $412,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 660K

0.08% 3M change

1.62% 12M change

Total Value Held $30.6 Million

Nello Mainolfi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 12 2021	SELL Open market or private sale	$412,662 $50.05 p/Share	8,245 Reduced 2.03%	397,199 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$17,150 $2.08 p/Share	8,245 Added 1.99%	405,444 Common Stock
Apr 26 2021	SELL Open market or private sale	$111,218 $40.18 p/Share	2,768 Reduced 0.69%	397,199 Common Stock
Apr 26 2021	BUY Exercise of conversion of derivative security	$5,757 $2.08 p/Share	2,768 Added 0.69%	399,967 Common Stock
Apr 23 2021	SELL Open market or private sale	$27,207 $40.01 p/Share	680 Reduced 0.17%	397,199 Common Stock
Apr 23 2021	BUY Exercise of conversion of derivative security	$1,414 $2.08 p/Share	680 Added 0.17%	397,879 Common Stock
Apr 22 2021	SELL Open market or private sale	$441,209 $40.26 p/Share	10,959 Reduced 2.68%	397,199 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$22,795 $2.08 p/Share	10,959 Added 2.61%	408,158 Common Stock
Apr 19 2021	SELL Open market or private sale	$26,120 $40.0 p/Share	653 Reduced 0.17%	391,199 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$13,838 $2.08 p/Share	6,653 Added 1.65%	397,199 Common Stock
Apr 15 2021	SELL Open market or private sale	$199,033 $40.29 p/Share	4,940 Reduced 1.25%	391,199 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$10,275 $2.08 p/Share	4,940 Added 1.23%	396,139 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$31,200 $2.08 p/Share	15,000 Added 3.69%	391,199 Common Stock
Apr 12 2021	SELL Open market or private sale	$500,910 $32.81 p/Share	15,267 Reduced 3.9%	376,199 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$31,755 $2.08 p/Share	15,267 Added 3.75%	391,466 Common Stock
Apr 09 2021	SELL Open market or private sale	$772,489 $33.89 p/Share	22,794 Reduced 5.71%	376,199 Common Stock
Apr 09 2021	BUY Exercise of conversion of derivative security	$47,412 $2.08 p/Share	22,794 Added 5.4%	398,993 Common Stock
Apr 08 2021	SELL Open market or private sale	$350,052 $35.22 p/Share	9,939 Reduced 2.57%	376,199 Common Stock
Apr 08 2021	BUY Exercise of conversion of derivative security	$20,673 $2.08 p/Share	9,939 Added 2.51%	386,138 Common Stock

Nello Mainolfi

Chief Executive Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account